Unknown

Dataset Information

0

Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort.


ABSTRACT: Novel biological subtypes and clinically important genetic aberrations (druggable lesions, prognostic factors) have been described in B-other acute lymphoblastic leukemia (ALL) during the last decade; however, due to a lack of studies on unselected cohorts, their population frequency and mutual associations still have to be established. We studied 110 consecutively diagnosed and uniformly treated childhood B-other patients using single nucleotide polymorphism arrays and whole exome/transcriptome sequencing. The frequency of DUX4-rearranged, BCR-ABL1-like, ZNF384-rearranged, ETV6-RUNX1-like, iAMP21 and MEF2D-rearranged subtypes was 27%, 15%, 5%, 5%, 4%, and 2%, respectively; 43% of cases were not classified into any of these subtypes (B-rest). We found worse early response to treatment in DUX4-rearranged leukemia and a strong association of ZNF384-rearranged leukemia with B-myeloid immunophenotype. Of the druggable lesions, JAK/STAT-class and RAS/RAF/MAPK-class aberrations were found in 21% and 43% of patients, respectively; an ABL-class aberration was found in one patient. A recently described negative prognostic factor, IKZF1plus , was found in 14% of patients and was enriched in (but not exclusive for) BCR-ABL1-like subtype. PAX5 fusions (including 4 novel), intragenic amplifications and P80R mutations were mutually exclusive and only occurred in the B-rest subset, altogether accounting for 20% of the B-other group. PAX5 P80R was associated with a specific gene expression signature, potentially defining a novel leukemia subtype. Our study shows unbiased European population-based frequencies of novel ALL subtypes, recurrent (cyto)genetic aberrations and their mutual associations. This study also strengthens and widens the current knowledge of B-other ALL and provides an objective basis for optimization of current genetic diagnostics.

SUBMITTER: Zaliova M 

PROVIDER: S-EPMC6601078 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort.

Zaliova Marketa M   Stuchly Jan J   Winkowska Lucie L   Musilova Alena A   Fiser Karel K   Slamova Martina M   Starkova Julia J   Vaskova Martina M   Hrusak Ondrej O   Sramkova Lucie L   Stary Jan J   Zuna Jan J   Trka Jan J  

Haematologica 20190110 7


Novel biological subtypes and clinically important genetic aberrations (druggable lesions, prognostic factors) have been described in B-other acute lymphoblastic leukemia (ALL) during the last decade; however, due to a lack of studies on unselected cohorts, their population frequency and mutual associations still have to be established. We studied 110 consecutively diagnosed and uniformly treated childhood B-other patients using single nucleotide polymorphism arrays and whole exome/transcriptome  ...[more]

Similar Datasets

| S-EPMC9700506 | biostudies-literature
| S-EPMC5243866 | biostudies-literature
| S-EPMC5535770 | biostudies-literature
| S-EPMC3919793 | biostudies-literature
| S-EPMC9873558 | biostudies-literature
| S-EPMC10352600 | biostudies-literature
2023-03-13 | GSE184692 | GEO
| S-EPMC10776399 | biostudies-literature
| S-EPMC10600232 | biostudies-literature
| S-EPMC5396319 | biostudies-literature